Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up

European Journal of Heart Failure

Volumn 19, Issue 8, 2017, Pages 1075-1076

  Van Aelst, Lucas N L ^a   Abraham, Marjorie ^b,c   Sadoune, Malha ^c   Lefebvre, Thibaud ^d,e   Manivet, Philippe ^b,c   Logeart, Damien ^b,c,f   Launay, Jean Marie ^b,c   Karim, Zoubida ^d,e   Puy, Hervé ^d,e   Cohen Solal, Alain ^b,c,f  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HÔPITAL LARIBOISIÈRE   (France)

^c University of Paris   (France)

^d CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^e IMAGINE INSTITUTE   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

biomarkers; ferritin; Heart failure; hepcidin; iron deficiency; treatment

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FERRITIN; FIBRINOGEN; GALECTIN 2; GROWTH DIFFERENTIATION FACTOR 15; HEPCIDIN; INTERLEUKIN 6; MYELOPEROXIDASE; PROADRENOMEDULLIN; PROCALCITONIN; TUMOR NECROSIS FACTOR; IRON;

ACUTE HEART FAILURE; AGED; BLOOD CHEMISTRY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FIBROSIS; FOLLOW UP; HOSPITALIZATION; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; KIDNEY FUNCTION; LETTER; MALE; PRIORITY JOURNAL; RELIABILITY; TRANSFERRIN BLOOD LEVEL; ACUTE DISEASE; BLOOD; HEART FAILURE; HOSPITAL PATIENT; PATHOPHYSIOLOGY; TIME FACTOR;

ACUTE DISEASE; AGED; BIOMARKERS; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INPATIENTS; IRON; MALE; TIME FACTORS;

EID: 85019588638     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.837     Document Type: Letter

References (7)

1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891–975.
2. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872–1880.
3. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013;165:575–582.
4. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436–2448.
5. Cohen-Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, Zannad F, Laperche T, Leclercq C, Concas V, Duvillie L, Darne B, Anker S, Mebazaa A. High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 2014;16:984–991.
6. Seronde MF, Gayat E, Logeart D, Lassus J, Laribi S, Boukef R, Sibellas F, Launay JM, Manivet P, Sadoune M, Nouira S, Solal AC, Mebazaa A; Great Network. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure. Int J Cardiol 2013;168:3404–3411.
7. Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Oleskowska-Florek W, Zymlinski R, Biegus J, Siwolowski P, Banasiak W, Anker SD, Filippatos G, Cleland JG, Ponikowski P. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 2014;35:2468–2476.